000 01177 a2200349 4500
005 20250517195410.0
264 0 _c20190917
008 201909s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/bjh.15088
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoudra, Alena
245 0 0 _aNQO1*2 polymorphism predicts overall survival in MDS patients.
_h[electronic resource]
260 _bBritish journal of haematology
_c01 2019
300 _a305-308 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMyelodysplastic Syndromes
_xenzymology
650 0 4 _aNAD(P)H Dehydrogenase (Quinone)
_xgenetics
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aSurvival Rate
700 1 _aMinarik, Lubomir
700 1 _aVancurova, Marketa
700 1 _aBartek, Jiri
700 1 _aHodny, Zdenek
700 1 _aJonasova, Anna
773 0 _tBritish journal of haematology
_gvol. 184
_gno. 2
_gp. 305-308
856 4 0 _uhttps://doi.org/10.1111/bjh.15088
_zAvailable from publisher's website
999 _c28008963
_d28008963